LogicBio Therapeutics (LOGC) Financials

$14.45

$7.77 (116.32%)

As on 11-Sep-2026 15:59EDT

Market cap

$593 Mln

Revenue (TTM)

$32 Mln

P/E Ratio

--

P/B Ratio

2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	--	43.00	287.00	571.00	2,085.00	2,541.00
Cost of Revenue	--	36.00	228.00	405.00	977.00	947.00
Gross Profit	--	7.00	59.00	166.00	1,108.00	1,594.00
Operating Expenses	31.00	86.00	387.00	564.00	1,475.00	2,225.00
Operating Profit (EBIT)	-31.00	-79.00	-328.00	-398.00	-367.00	-631.00
Other Income	--	--	--	--	--	--
Profit before Tax	-23.00	-69.00	-312.00	-383.00	-351.00	-743.00
Provision for Tax	--	6.00	5.00	1.00	10.00	2.00
Profit after Tax (Net Income)	-29.00	-75.00	-317.00	-384.00	-361.00	-745.00
Minority Interest	-6.00	--	--	--	--	--
Consolidated Profit	--	--	--	-384.00	-361.00	-745.00

Liabilities ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	133.00	151.00	217.00	477.00	818.00	1,027.00
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	10.00	13.00	16.00	38.00
Current Liabilities	7.00	5.00	196.00	309.00	449.00	1,332.00
Total Liabilities	218.00	156.00	423.00	799.00	1,283.00	2,397.00

Assets ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	--	--	13.00	22.00	59.00	83.00
Current Assets	218.00	156.00	410.00	777.00	1,224.00	2,314.00
Total Assets	--	156.00	423.00	799.00	1,283.00	2,397.00
Total Debt*	--	--	6.00	13.00	16.00	38.00
Net Current Assets	211.00	151.00	214.00	468.00	775.00	982.00

Cashflow ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	-16.00	-94.00	-341.00	-422.00	-951.00	-28.93
Cash Flow from Investing Activities	--	--	--	-47.00	-3.00	165.00
Cash from Financing Activities	72.00	-1.00	-5.00	-22.00	7.00	1,046.00
Net Cash Inflow / Outflow	--	--	--	--	-947.00	1,211.00

Financials Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	--	-2.85	-13.14	-16.74	-11.22	-31.57
Cash EPS ($)	--	-2.81	-12.98	-16.48	-10.94	-31.06
Adjusted Book Value ($)	--	5.74	9.00	20.80	25.43	43.52
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-3.58	-14.14	-18.40	-29.57	-1.23
Free Cash Flow per Share ($)	--	-3.58	-14.26	-18.49	-29.63	-1.31

Profitability Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	-20.42	-40.11	-88.92	-58.01	-38.02	448.80
ROE (%)	-20.42	-40.76	-91.35	-59.31	-39.13	361.65
ROA (%)	-15.51	-25.91	-51.88	-36.89	-19.62	-39.60
EBIT Margin (%)	--	-183.72	-114.29	-69.70	-17.60	-24.83
Net Margin (%)	--	-174.42	-110.45	-67.25	-17.31	-29.32
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	-1.00	-0.85	-0.50	-0.73	-0.18	0.74
EBIT Growth (%)	--	75.91	17.59	-8.45	41.84	-338.19
Net Profit Growth (%)	61.33	76.34	17.45	-6.37	51.54	-477.52
EPS Growth (%)	--	0.78	0.22	-0.49	0.64	-4.67
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-2.46	--	--	-0.21	-0.24
Price / Book Value	--	1.22	--	--	0.09	0.18
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	--	-0.46	--	--	2.99	3.09
Close Price ($)	--	7.03	--	--	2.31	7.63
High Price ($)	--	8.21	--	--	9.75	11.60
Low Price ($)	--	4.92	--	--	2.15	3.05
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	--	0.03	0.03	0.02	0.04
Short term debt to equity ratio	--	--	0.70	0.49	0.01	0.00
Current Ratio	31.14	31.20	2.09	2.51	2.73	1.74
Quick Ratio	--	--	--	--	2.73	1.74
Interest Coverage	--	--	--	-26.53	-22.96	-574.68

Operating Efficiency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	--	--	2.44	2.45	0.82	3.27
Asset Turnover	--	0.15	0.47	0.55	1.13	1.35
Receivable days	--	59.46	13.36	9.91	8.76	12.79
Inventory Days	--	--	--	-1.94	-0.82	-0.85
Payable days	--	152.19	66.48	54.11	93.65	116.67
Cash Conversion Cycle	--	--	--	-46.14	-85.71	-104.73